Vaxcyte, Inc.
PCVX
$54.03
$0.040.07%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 1.74B | 1.56B | 1.71B | 1.66B | 1.67B |
| Total Receivables | -- | 46.56M | 400.00K | 100.00K | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 76.31M | 17.04M | 55.45M | 54.25M | 44.83M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | 2.80M | -- | -- | -- |
| Total Current Assets | 1.81B | 1.63B | 1.77B | 1.72B | 1.72B |
|
|
|||||
| Total Current Assets | 1.81B | 1.63B | 1.77B | 1.72B | 1.72B |
| Net Property, Plant & Equipment | 373.80M | 373.38M | 337.00M | 327.92M | 304.91M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 157.01M | 120.31M | 108.18M | 96.58M | 77.60M |
| Total Assets | 3.35B | 3.00B | 3.17B | 3.31B | 3.38B |
|
|
|||||
| Total Accounts Payable | 63.06M | 70.90M | 48.96M | 31.41M | 20.51M |
| Total Accrued Expenses | 172.94M | 128.72M | 145.31M | 116.77M | 70.35M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 6.09M | 6.12M | 5.77M | 6.30M | 6.13M |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 242.08M | 205.75M | 200.05M | 154.49M | 97.00M |
|
|
|||||
| Total Current Liabilities | 242.08M | 205.75M | 200.05M | 154.49M | 97.00M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 110.21M | 111.36M | 78.67M | 79.54M | 81.08M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | 100.00K | -- | -- | -- |
| Total Liabilities | 352.29M | 317.21M | 278.72M | 234.03M | 178.08M |
|
|
|||||
| Common Stock & APIC | 5.48B | 4.84B | 4.80B | 4.77B | 4.73B |
| Retained Earnings | -2.48B | -2.15B | -1.91B | -1.70B | -1.53B |
| Treasury Stock & Other | -6.83M | 1.59M | 856.00K | -1.89M | -322.00K |
| Total Common Equity | 3.00B | 2.69B | 2.89B | 3.07B | 3.20B |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 3.00B | 2.69B | 2.89B | 3.07B | 3.20B |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 3.00B | 2.69B | 2.89B | 3.07B | 3.20B |
|
|
|||||